<DOC>
	<DOCNO>NCT02169908</DOCNO>
	<brief_summary>The role oxidative stress development oxaliplatin-induced peripheral neuropathy previously describe mice neuronal cell culture ( Massicot 2013 ) ; clinical manifestation pathophysiological mechanism potentially involve also describe human ( Andreas 2007 ) ( Attal 2009 ) . The investigator team plan conduct translational clinicobiological research explain nature biochemical molecular mechanism development oxaliplatin-induced painful neuropathy . To perform project , investigator propose realize pilot study patient newly treat oxaliplatin . This conducted oncology department Paris Saint Joseph Hospital May 2014 inclusion 20 patient . The main objective pilot study evaluate occurrence acute chronic neuropathic pain occur patient newly treat oxaliplatin . The characterization pain base validated test ( Cruccu 2010 ) . Moreover , biochemical change relate oxidative stress relate cellular lipid composition characterize patient .</brief_summary>
	<brief_title>Analysis Chronic Neuropathic Pain Markers Patients Treated With Oxaliplatin</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patient newly traeted oxaliplatin Patient suffer type cancer treat oxaliplatin Man Woman 18 Patient brain leptomeningeal metastases Patient previously treat cisplatin Patient addict alcohol Diabetic patient peripheral neurological disorder Patient receive calcium magnesium salt intravenously Patient suffer peripheral neuropathy Patient suffer psychiatric disorder Patient treat least one follow drug : venlafaxine , carbamazepine , gabapentin , pregabalin , clomipramine , amitriptyline , imipramine , duloxetine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>